Dai Nakashima
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 4
- Oncology top 10%
- Peptidase Inhibition and Analysis 6
- Cancer-related Molecular Pathways 6
- Otorhinolaryngology top 5%
- Molecular Biology top 10%
- Cancer-related gene regulation 7
- RNA modifications and cancer 7
- RNA Research and Splicing 5
- Cell Biology top 10%
-
- Oral and Maxillofacial Pathology 9
-
- Salivary Gland Tumors Diagnosis and Treatment 7
- Co-authors
- Hideki TanzawaKatsuhiro UzawaAtsushi KasamatsuMasashi ShiibaKatsunori OgawaraMorihiro HigoHirofumi KoikeKazuki Saito
- Partner nations
- JapanUnited KingdomUnited States
In The Last Decade
Dai Nakashima
48 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 89
- Cancer Research 328
- Oncology 346
- Otorhinolaryngology 53
- Molecular Biology 832
- Cell Biology 178
Countries citing papers authored by Dai Nakashima
This map shows the geographic impact of Dai Nakashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dai Nakashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dai Nakashima more than expected).
Fields of papers citing papers by Dai Nakashima
This network shows the impact of papers produced by Dai Nakashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dai Nakashima. The network helps show where Dai Nakashima may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dai Nakashima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 45 | |
| 2 | 2019 | 4 | |
| 3 | 2018 | 14 | |
| 4 | 2018 | 22 | |
| 5 | 2017 | 30 | |
| 6 | 2016 | 16 | |
| 7 | 2016 | 17 | |
| 8 | 2016 | 29 | |
| 9 | 2016 | 17 | |
| 10 | 2015 | 20 | |
| 11 | 2013 | 66 | |
| 12 | 2012 | 1 | |
| 13 | 2012 | 5 | |
| 14 | Loss of heterozvgosity in oral cancer | 2011 | 0 |
| 15 | 2010 | 66 | |
| 16 | 2009 | 80 | |
| 17 | 2008 | 21 | |
| 18 | 2007 | 23 | |
| 19 | 2006 | 18 | |
| 20 | 2005 | 23 |
About Dai Nakashima
Dai Nakashima is a scholar working on Oral Surgery, Cancer Research and Oncology, having authored 49 papers that have together received 1.2k indexed citations. Recurring topics across this work include Oral and Maxillofacial Pathology (9 papers), Cancer-related gene regulation (7 papers), RNA modifications and cancer (7 papers), Salivary Gland Tumors Diagnosis and Treatment (7 papers), Peptidase Inhibition and Analysis (6 papers), Cancer-related Molecular Pathways (6 papers), RNA Research and Splicing (5 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Cancer Research (328 citations), Oncology (346 citations) and Otorhinolaryngology (53 citations). Dai Nakashima has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Hideki Tanzawa, Katsuhiro Uzawa, Atsushi Kasamatsu, Masashi Shiiba, Katsunori Ogawara, Morihiro Higo, Hirofumi Koike, Kazuki Saito, Hidetaka Yokoe and Yosuke Endo‐Sakamoto. Their work appears in journals such as PLoS ONE, Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.